Drug giant Bayer has rarely seen risk-taking as a cure for its ills. But next month’s relocation of its general medicine headquarters from Germany to Beijing will make Bayer AG the first multinational pharmaceutical company to open a global corporate cent
Bayer’s Big Bet On China